FDA Approved: TARPEYO — Supplemental Application (Calliditas Therapeutics AB)

View source ↗

Summary

FDA approved a supplemental application for Tarpeyo (budesonide) submitted by Calliditas Therapeutics AB.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• Tarpeyo (budesonide)

Snippet

SUPPL AP for TARPEYO (BUDESONIDE)